Cart
sales@molnova.com
Ralmitaront
CAS No. 2133417-13-5
Ralmitaront( RO6889450 )
Catalog No. M23969 CAS No. 2133417-13-5
Ralmitaront is a potent, orally active partial agonist of the trace amine-associated receptor 1 (TAAR1).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 267 | In Stock |
|
| 10MG | 434 | In Stock |
|
| 25MG | 669 | In Stock |
|
| 50MG | 896 | In Stock |
|
| 100MG | 1269 | In Stock |
|
| 200MG | 1701 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRalmitaront
-
NoteResearch use only, not for human use.
-
Brief DescriptionRalmitaront is a potent, orally active partial agonist of the trace amine-associated receptor 1 (TAAR1).
-
DescriptionRalmitaront is a potent, orally active partial agonist of the trace amine-associated receptor 1 (TAAR1).
-
In Vitro——
-
In Vivo——
-
SynonymsRO6889450
-
PathwayOthers
-
TargetOther Targets
-
Recptoramine-associated receptor 1 (TAAR1)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2133417-13-5
-
Formula Weight314.38
-
Molecular FormulaC17H22N4O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:90mg/ml(286.28mM; Need ultrasonic)
-
SMILESCCc1c(C)c(C(Nc2ccc([C@@H]3OCCNC3)cc2)=O)n[nH]1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Brady LS, Potter WZ, Gordon JA. Redirecting the revolution: new developments in drug development for psychiatry. Expert Opin Drug Discovery. 2019;14:1213–1219.
molnova catalog
related products
-
Cortagine
Potent and selective corticotrophin releasing factor receptor 1 (CRF1) agonist (EC50 = 0.18 nM for rat CRF1). Displays anxiolytic and antidepressant activity in vivo. Microinfusion into mouse prefrontal cortex reduces defensive behavior in vivo.
-
MHI-148
MHI-148 is a tumor-targeting near-infrared heptamethylenecarbocyanine dye for the detection, diagnosis, and study of cancer.
-
cGMP Dependent Kinas...
Competitive inhibitor of cGMP-dependent protein kinase (PKG); analog of a substrate peptide corresponding to a phosphorylation site of histone H2B. Competes with synthetic substrates (Ki = 86 mM) but does not inhibit phosphorylation of intact histones by PKG. Inhibits phosphorylation of intact histones by PKA.
